MedPath

Reducing Anxiety Levels Through the Dharma Life App-Based and Mentor-Based Program Targeting Personality Characteristics: A Randomized Control Trial

Not Applicable
Completed
Conditions
Anxiety
Interventions
Behavioral: App
Registration Number
NCT06138652
Lead Sponsor
Dharma Life Sciences LLC
Brief Summary

The purpose of this study was to examine whether an app- and mentor-based program reduced anxiety among individuals reporting difficulties with anxiety.

For the intervention group, this study involved completing an 8-week program focused on helping participants reach their personality goals. The program involved app-based games, journaling, and completing behavioral challenges. Participants engaged with the study app for approximately 15 minutes per day and spoke with a study mentor weekly for 1 hour. Participants were asked to complete surveys prior to and after the program. The pre-program survey lasted approximately 1 hour, and the post-program survey lasted approximately 30 minutes.

For the control group, this study involved completing surveys. Participants were asked to complete surveys 8 weeks apart. The first batch of surveys lasted approximately 1 hour, and the follow-up surveys lasted approximately 30 minutes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
73
Inclusion Criteria
  • Moderate to severe anxiety levels based on the BAI and GAD-7
Exclusion Criteria
  • We excluded participants experiencing any of the following self-reported behaviors in the past 6 months: substance abuse, self-harm, harm or destruction of another person or their property, suicidal ideations, and feeling helpless after the death of a loved one

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AppAppParticipants completed surveys at baseline and again after 8 weeks. Participants completed app-based games and consultation with a mentor over an 8 week period focused on alleviating anxiety.
Primary Outcome Measures
NameTimeMethod
Beck Anxiety InventoryBaseline and after 8 weeks

Self report survey of anxiety symptoms

GAD-7Baseline and after 8 weeks

Self report survey of anxiety symptoms

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dharma Life Sciences

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath